Patients with lung cancer have higher breath temperature
the ONA take:
According to new research presented at the European Respiratory Society (ERS) International Congress in Munich, Germany, testing the temperature of breath may be an easy method to diagnose patients with lung cancer. In the study, researchers identified 82 patients to receive a breath temperature test after an x-ray examination suggested a diagnosis of lung cancer.
Researchers measured the patients' breath using an X-Halo device, a thermometer for breath. The X-Halo device confirmed lung cancer in 40 patients and rejected the diagnosis in 42 patients.
The researchers found that the patients with lung cancer had an increased breath temperature compared with those without lung cancer. In addition, the temperature rose with their lung cancer stage and the duration in which a patient had smoked. The researchers were also able to identify the cut-off temperature for which lung cancer could be proven accurately.
Researchers hope that they can refine this test to be used to diagnose patients with lung cancer by measuring their breath temperature. They suggest that the test would be simple, cheap, and noninvasive.
Testing the temperature of breath may be an easy method to diagnose patients with lung cancer.
The temperature of exhaled breath could be used to diagnose lung cancer, according to a new study. The research, presented at the European Respiratory Society (ERS) International Congress in Munich today (8 September 2013), suggests that testing the temperature of breath could be a simple and noninvasive method to either confirm or reject the presence of lung cancer.
Many research teams have been looking at the possibility of using breath tests for a number of cancers. This is the first study looking at breath temperature as a marker in lung cancer.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|